macrolides (and other antibiotics), are still recommended as the first-line (and second-line antibiotics) for the MP infection. However, it has been a long-term controversy on the effect of antibiotics on MP infection in children and in adults; Cochrane review concluded that there was insufficient evidence of the efficacy of antibiotics on MP pneumonia in children (Gardiner SJ, et al. Cochrane Database Syst Rev 2015; 1:CD004875) . -In the early stage of MP pneumonia, serologic tests or PCR test have some limitations because of the absence of IgM antibody response and long-term IgM positive for MP, especially in severe cases. Therefore, repeated IgM test are necessary for early confirmative diagnosis during hospitalization (Lee SC, et al. Medicine (Baltimore). 2016; 95(19) :e3605).
-The precise mechanisms of lung cell injury in pneumonia resulted from various pathogens, including severe MPP, remain unknown; pathogen-related substances or other substances from injured host cells during host hyperactive immune reactions may be responsible for lung cell injury (Lee KY. Infect Chemother 2015; 47(1):12-26) . Therefore, it is a natural concept that severe pneumonia patients have more severe lung injury requiring longterm recovery time, and more severe laboratory parameter values such as CRP, LDH, and some cytokines. Because the immunopathogenesis of mild and severe pneumonia may be the same, early control of the initial hyper-immune disturbance is crucial. LDH level may be associated with true lung cell injury, and subsequent prolonged recovery period of tissue repair. It is reasonable to recommend that the early use of immunemodulators, without waiting for the antibiotic's effect, contributes to the effective reduction of immune-mediated lung injury in MP infection (Lee KY. Int J Mol Sci 2017;18(2): E388). Therefore, the authors should focus on these points in the Discussion, and they could find the facts in their clinical data that late-administration or small-dose of corticosteroids (MP) is associated with prolonged fever duration and severe lung injury, and some severe patients might be needed higher dose of corticosteroids as shown their previous observation (Ref. 6) . I think that patients in this series could have less severe morbidity if patients were treated with early as soon as possible at presentation, with enough-dose of corticosteroids for severe patients. The authors could plan to perform the study regarding early steroid therapy in coming next MP epidemic in China.
Specific comments 1) The authors should add more information for patient selection; the rates of positivity of anti-MP IgM & IgG at presentation and FU (> 2 weeks), and PCR. As macrolide resistance mycoplasma is very common across China, were the patients tested for macrolide resistance MP? They could describe the treatment policy for patients infected with macrolide-resistant MPP in their institution. 2) They should briefly discuss on the rationale of bronchoscopy study in MPP, and was it performed for therapy or diagnosis or both? And, it would be better to add information about BAL findings, including cell composition of mucus plug, in RMMP patients, and add more photos of endoscopic findings of mucus plug, including mild, moderate, and severe cases. The photos in this study were same ones as shown in their previous study (Ref. 6) . It is strange that patients who received BAL study (the patients with mucus plug) had more severe clinical and late chest radiographic outcomes in this study, and it was opposite to the results in other studies (Ref. 7); removal of mucus plug might be an alternative therapy for rapid clinical improvement in RMPP. 3) They should re-confirm or evaluate the data for the number of patients with mucus plug formation, and the number of patients with clear lung lesions within 4 weeks in this study, because the data of these parameters are somewhat different compared to their previously study (Ref. 6 ) and patient might be selected in a same recent MP pneumonia epidemic, having 1-2 years epidemic period. 4) The authors could conclude and discuss on that clinical parameters, including total fever duration, lung-lesion clear time, mucus plug, steroid use timing (or preadmission fever duration), and initial steroid-dose in the steroid treated group, and values of laboratory parameters such as CRP, Lymphocyte%, and LDH were related with each other and severity of the diseases. Also, they could use total MPP patients during study period, including mild and no-RMMP patients.
REVIEWER
Metaxas 
GENERAL COMMENTS
Mycoplasma pneumoniae is a major cause of childhood community-acquired pneumonia (CAP). M. pneumoniae infections are generally mild. However, refractory Mycoplasma Pneumoniae pneumonia (RMPP), which has been suggested to be linked to excessive cytokines, are increasingly common in recent decades. RMPP are often resistant to macrolides and often show no improvement in clinical and radiological findings. Corticosteroids has been shown to be effective in treating RMPP. However, some patients with RMPP still have fever persisting and radiological deterioration. Bronchoscopy often reveal mucus plug formation. In this study, Huang et al performed a prospective to study of the radiographic clearance of RMPP in immunocompetent children, and to identify independent predictors of time to complete radiographic resolution. The authors examined RMPP patients treated with bronchoscopy were prospectively enrolled in the study between Jan 2011 and Dec 2015. Multivariate logistic regression was performed to identify independent predictors of time to complete radiographic resolution. The found that of the 187 RMPP patients, bronchial mucus plugs formation was detected in 39.0% patients. They also found that CRP ≥50 mg/L, LDH ≥480 U/L, fever duration ≥10 days and presence of mucus plugs were associated with a longer time to radiographic clearance. Finally, they found that when compared against those children without mucus plugs, those with mucus plugs were significantly more likely to have a longer time to radiographic clearance. The authors concluded that clinical parameters include duration of fever, CRP, LDH and presence of mucus plugs will be good indicators to identify RMPP children who likely will need a longer time to radiographic clearance. Overall, the conclusions are generally in line with the presented data. The authors are to be commended for pointing out various limitations of their study. Appropriate statistical analyses were performed. The manuscript has been fairly well written and concise. However, it could be improved with a couple rounds of editing from professional editor.
Comments: 
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1:
In this paper, the authors described that some factors, including bronchial mucus plug, were associated with delayed chest radiographic clearance in severe Mycoplasma pneumoniae pneumonia (MPP), using a relatively large group of patients (187 cases). They suggested that clinicians might use the parameters of duration of fever, CRP, LDH and presence of mucus plugs to identify children at a longer time to radiographic clearance. Although the authors presented an interesting issue regarding the bronchial alveolar lavage (BAL) study, this study could not provide new information, and similar reports have been reported by the authors previously (Ref. 6) and other study groups for the issues.
Thus, the authors could discuss further regarding characteristics of MP infection, such as the reason of unresponsiveness to antibiotics and effectiveness of immune-modulators (corticosteroids or intravenous immunoglobulin) as they experienced during the recent MP epidemic (Ref. 6), and could rewrite the Title, Abstract, and Discussion after re-evaluation of the data.
I suggested a new sight of view for the issues. -The precise mechanisms of lung cell injury in pneumonia resulted from various pathogens, including severe MPP, remain unknown; pathogen-related substances or other substances from injured host cells during host hyperactive immune reactions may be responsible for lung cell injury (Lee KY. Infect Chemother 2015;47 (1):12-26). Therefore, it is a natural concept that severe pneumonia patients have more severe lung injury requiring long-term recovery time, and more severe laboratory parameter values such as CRP, LDH, and some cytokines. Because the immunopathogenesis of mild and severe pneumonia may be the same, early control of the initial hyper-immune disturbance is crucial. LDH level may be associated with true lung cell injury, and subsequent prolonged recovery period of tissue repair. It is reasonable to recommend that the early use of immune-modulators, without waiting for the antibiotic's effect, contributes to the effective reduction of immune-mediated lung injury in MP infection (Lee KY. Int J Mol Sci 2017;18(2): E388). Therefore, the authors should focus on these points in the Discussion, and they could find the facts in their clinical data that late-administration or small-dose of corticosteroids (MP) is associated with prolonged fever duration and severe lung injury, and some severe patients might be needed higher dose of corticosteroids as shown their previous observation (Ref. 6). I think that patients in this series could have less severe morbidity if patients were treated with early as soon as possible at presentation, with enough-dose of corticosteroids for severe patients. The authors could plan to perform the study regarding early steroid therapy in coming next MP epidemic in China.
Response: Thanks so much for new sight. We have added some of them which were closely related with our present study in our discussion. As the reviewer suggested, we will perform the study regarding early steroid therapy and the other suggestions in coming next MP epidemic in China.
Specific comments
1) The authors should add more information for patient selection; the rates of positivity of anti-MP IgM & IgG at presentation and FU (> 2 weeks), and PCR. As macrolide resistance mycoplasma is very common across China, were the patients tested for macrolide resistance MP? They could describe the treatment policy for patients infected with macrolide-resistant MPP in their institution.
Response: we have added more information for patient selection. the rates of positivity of anti-MP IgM & IgG at presentation and FU (> 2 weeks), and PCR were also added. in our study, the patients were not tested for Macrolide resistance MP. But due to its importance, we woud do it in our future work.
2) They should briefly discuss on the rationale of bronchoscopy study in MPP, and was it performed for therapy or diagnosis or both? And, it would be better to add information about BAL findings, including cell composition of mucus plug, in RMMP patients, and add more photos of endoscopic findings of mucus plug, including mild, moderate, and severe cases. The photos in this study were same ones as shown in their previous study (Ref. 6) . It is strange that patients who received BAL study (the patients with mucus plug) had more severe clinical and late chest radiographic outcomes in this study, and it was opposite to the results in other studies (Ref. 7) ; removal of mucus plug might be an alternative therapy for rapid clinical improvement in RMPP.
Response: it is a prospective study for MPP, all the patients were confirmed as MPP. So bronchoscopy was performed for therapy, we have added this in the Discussion. BAL findings were added in our manuscript, while cell compositions of mucus plug were not performed in our study. we have added more photos of endoscopic findings of mucus plug.
In the study (Ref. 7), the authors compared the effect between early use (≤ 3 days after admission) and late use (>3 days) of bronchoscopy. They concluded that early use of bronchoscopy may render greater benefit in children with RMPP. However, in our study, we did not focus on the timing of the bronchoscopy use after admission. We focus on the relationship between the endoscopic findings and radiographic resolution time. We found that those with mucus plugs were significantly more likely to have a longer time to radiographic clearance. Mucus plugs formation was a manifestation of severe cilia abnormalities which were responsible for delayed radiographic resolution. So our results were not opposite to the results in other studies (Ref. 7).
3) They should re-confirm or evaluate the data for the number of patients with mucus plug formation, and the number of patients with clear lung lesions within 4 weeks in this study, because the data of these parameters are somewhat different compared to their previously study (Ref. 6 ) and patient might be selected in a same recent MP pneumonia epidemic, having 1-2 years epidemic period.
Response: the study period of our previously study (Ref. 6) was not totally same as this study, although they are in a same recent MP pneumonia epidemic. We have confirmed our data. As the study aim, included and excluded criteria were not the same. The final included patients may different.
4) The authors could conclude and discuss on that clinical parameters, including total fever duration, lung-lesion clear time, mucus plug, steroid use timing (or preadmission fever duration), and initial steroid-dose in the steroid treated group, and values of laboratory parameters such as CRP, Lymphocyte%, and LDH were related with each other and severity of the diseases. Also, they could use total MPP patients during study period, including mild and no-RMMP patients.
